Mitochondrial dysfunction in Alzheimer’s disease - a proteomics perspective
Morteza Abyadeh(Virginia Commonwealth University), Mehdi Mirzaei(Australian Hearing), Yuyi You(The University of Sydney), Nitin Chitranshi(Macquarie University), Vivek Gupta(Edith Cowan University), Paul A. Haynes(Macquarie University), Danit Saks(AGRF Ltd), Roshana Vander Wall(Deakin University), Matthew J. Fitzhenry(AGRF Ltd), Stuart L. Graham(University of Warwick), Devaraj Basavarajappa(Macquarie University), Yunqi Wu(AGRF Ltd), Ghasem Hosseini Salekdeh(Macquarie University)
Cited by 49
Related Papers
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis
|The Lancet Public Health|2022|350
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
|EClinicalMedicine|2023|132
Amyloid-beta and tau protein beyond Alzheimer’s disease
|Neural Regeneration Research|2023|98
Choroid plexus volume in multiple sclerosis predicts expansion of chronic lesions and brain atrophy
|Annals of Clinical and Translational Neurology|2022|89